Alimta – Pemetrexetd Injection
Pemetrexetd (Alimta) Injection – Treatment for Lung Cancer
Pemetrexetd or Alimta Injection is a cancer medication that is used to treat non-small cell lung cancer and malignant pleural mesothelioma.
Non-small cell lung cancer is one of the most common types of lung cancer, affecting both smokers and nonsmokers. Alimta Injection is used to treat non-small cell lung cancer and can be used alone or in conjunction with other medications. It is a potent and highly poisonous medication, and you should consult your doctor about the dangers and advantages.
Alimta Injection is administered through injection by a trained medical expert. Your doctor will determine the appropriate dose and frequency of administration. This will vary depending on what you are being treated for and may alter over time.
USES OF PEMETREXETD (ALIMTA) INJECTION
- Non-small cell lung cancer
- Malignant pleural mesothelioma
WORKS OF PEMETREXETD (ALIMTA) INJECTION
Alimta Injection disrupts the growth of cancer cells’ DNA and RNA by swapping their building blocks. It inhibits the growth and multiplication of cancer cells.
SIDE EFFECTS OF PEMETREXETD (ALIMTA) INJECTION
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Sore throat
- Loss of appetite
- Stomatitis (Inflammation of the mouth)
- Hair loss
- Low blood platelets
- Anemia (low number of red blood cells)
WARNING & PRECAUTIONS
Alimta Injection may have negative effects that impair your ability to drive.
Alimta Injection may cause fatigue, which may impair your ability to drive.
In patients with kidney problems, Alimta Injection should be taken with caution. Alimta Injection dosage may need to be adjusted. Please consult your physician.
In individuals with moderate to severe kidney disease, the use of Alimta Injection is not advised.
In people with liver problems, Alimta Injection is most likely safe to use. Based on the current data, it appears that no dose change of Alimta Injection is required in these patients. Please consult your physician.
Alimta Injection should not be used during pregnancy because there is clear evidence of danger to the developing infant. However, if the advantages outweigh the hazards, the doctor may seldom prescribe it in life-threatening conditions. Please consult your physician.
Fedelty Health Care is a Pemetrexetd third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.